Your healthcare provider should do blood tests to check how well your liver is working before you begin treatment with IXEMPRA and as needed during treatment. If blood tests show that you have liver problems, do not receive injections of IXEMPRA along with capecitabine. If you have liver problems, taking these medicines together could increase your chance of serious infection and death due to a very low white blood cell count (neutropenia).
You should not have your injection of IXEMPRA if you are allergic to medicines that contain Cremophor® EL* (polyoxyethylated castor oil) and if you have a low white blood cell count or a low platelet count. Continue to full Important Safety Information below
IXEMPRA a prescription medicine, used to treat breast cancer when certain medicines have not worked or no longer work can be used alone or with capecitabine.
Did you mean: ?
Search was not able to find any articles about
No pages containing your search term(s) were found.
Please see the complete Important Safety Information, including boxed WARNING regarding liver disease.
IXEMPRA is a prescription medicine used to treat locally advanced or metastatic breast cancer following certain treatments. IXEMPRA can be used alone or with another cancer medicine called Xeloda® (capecitabine).
IXEMPRA is a trademark of Bristol-Myers Squibb Company. *Cremophor is a registered trademark of BASF AG. Xeloda is a registered trademark of Roche Laboratories. © 2010 Bristol-Myers Squibb, Princeton, New Jersey 08543 U.S.A. All rights reserved.
691US09WA1490110/10